Identification and external validation of a prognostic signature based on MAPK-related genes to evaluate survival prognosis and treatment efficacy in lung adenocarcinoma
This integrative multi-omics-based prognostic model provides robust predictive power and novel biological insights, serving as a practical tool for personalized prognosis evaluation and targeted therapeutic decision-making in LUAD.
Authors
- Yajie Zhou (ORCID: https://orcid.org/0009-0001-5450-3354)
- Haiwei Rao
- Lei Xie (ORCID: https://orcid.org/0000-0002-2303-9173)
- Zijian Hu (ORCID: https://orcid.org/0009-0004-6134-1842)
- Wenxiong Zhang (ORCID: https://orcid.org/0000-0003-2962-0847)
Institutions
- Nanchang University (CN)
- Second Affiliated Hospital of Nanchang University (CN)
Publication Details
- Journal
- Clinical and Experimental Medicine
- Published
- 2025-11-11
- DOI
- https://doi.org/10.1007/s10238-025-01925-3
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 0.00